Pharmaceutical PV DIV - FSB
Ended Awarded Last action
- Contract number
- SPE2DU26FEHZS
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $17,021
Award facts
- Contract value 100% obligated
- $17,021.36 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a firm fixed-price delivery order valued at $17,021.36 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. This delivery order, issued on December 17, 2025, represents one of multiple orders executed under DMS Pharmaceutical Group's single-award Indefinite Delivery Contract with the Defense Logistics Agency's Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) initiative. The parent contract, designated SPE2DR and awarded on November 13, 2025, carries a $499.999 billion ceiling value and extends through December 31, 2036, positioning DMS Pharmaceutical Group as a critical regional pharmaceutical supplier for Department of Defense military healthcare facilities worldwide. No set-aside designation was used for this delivery order, demonstrating the contractor's competitive capability in unrestricted federal procurement.
Under the PPV-G GEN V framework, DMS Pharmaceutical Group supplies a comprehensive range of pharmaceutical products and medical consumables to support DoD healthcare operations globally, including branded and generic prescription medications, biologics, vaccines, specialty pharmaceuticals, and medical devices. The contractor's product portfolio encompasses oncology treatments, immunosuppressants, emergency medications, surgical products, and routine pharmaceuticals. This delivery order to Park Ridge, Illinois represents the company's continued performance fulfilling the specialized pharmaceutical requirements of the federal military medical system under the broader $30.3 billion PPV-G GEN V acquisition strategy managed by the Defense Logistics Agency.
Quick answers
Who was awarded contract SPE2DU26FEHZS?
SPE2DU26FEHZS was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on December 17, 2025.
How much is contract SPE2DU26FEHZS worth?
The government has obligated $17,021 on SPE2DU26FEHZS.
Is contract SPE2DU26FEHZS an order under another contract?
Yes. SPE2DU26FEHZS is a delivery order under SPE2DU25D9415, an indefinite delivery contract.
Was contract SPE2DU26FEHZS competed?
The extent of competition for SPE2DU26FEHZS was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award